Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume 4, Issue 11, Pages 1681-1690
Publisher
Wiley
Online
2015-06-04
DOI
10.1002/adhm.201500235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Iron oxide-loaded nanotheranostics: Major obstacles to in vivo studies and clinical translation
- (2015) Nathalie Schleich et al. JOURNAL OF CONTROLLED RELEASE
- Comparison of Sorafenib-Loaded Poly (Lactic/Glycolic) Acid and DPPC Liposome Nanoparticles in the in Vitro Treatment of Renal Cell Carcinoma
- (2015) James Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer
- (2014) Zhiwen Zhang et al. BIOMATERIALS
- Advanced nanovehicles for cancer management
- (2014) L. Saenz del Burgo et al. DRUG DISCOVERY TODAY
- Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma
- (2014) Rodolfo Sacco Future Oncology
- Theranostic nanoparticles for future personalized medicine
- (2014) Ju Hee Ryu et al. JOURNAL OF CONTROLLED RELEASE
- Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors
- (2014) Jeane Chen et al. JOURNAL OF CONTROLLED RELEASE
- Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking
- (2014) Arthur Taylor et al. PLoS One
- Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy
- (2013) Aneta J. Mieszawska et al. BIOCONJUGATE CHEMISTRY
- Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
- (2013) Chang-Fang Wang et al. BIOMATERIALS
- Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro
- (2013) Lei Zhang et al. International Journal of Nanomedicine
- Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging
- (2013) N. Schleich et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Magnetic Nanoparticles for Tumor Imaging and Therapy: A So-Called Theranostic System
- (2013) Huining He et al. PHARMACEUTICAL RESEARCH
- Multifunctional nanocarriers
- (2012) Vladimir P. Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes
- (2012) Chengcheng Niu et al. BIOMATERIALS
- Molecular mechanisms of sorafenib action in liver cancer cells
- (2012) Melchiorre Cervello et al. CELL CYCLE
- Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
- (2012) L. Harivardhan Reddy et al. CHEMICAL REVIEWS
- Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles
- (2012) Hong Zhang et al. International Journal of Nanomedicine
- Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer
- (2012) Do Kim et al. Nanoscale Research Letters
- Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Shibo Lin et al. Liver Cancer
- Lipid nanoparticles for brain targeting I. Formulation optimization
- (2011) Paolo Blasi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A highly sensitive magnetite nanoparticle as a simple and rapid stem cell labelling agent for MRI tracking
- (2011) Hyunjin Kim et al. JOURNAL OF MATERIALS CHEMISTRY
- Iron oxide nanoparticles for targeted cancer imaging and diagnostics
- (2011) Joshua E. Rosen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3
- (2011) Fang-Ming Gu WORLD JOURNAL OF GASTROENTEROLOGY
- Nanoparticle-based theranostic agents
- (2010) Jin Xie et al. ADVANCED DRUG DELIVERY REVIEWS
- Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
- (2010) Morteza Mahmoudi et al. ADVANCED DRUG DELIVERY REVIEWS
- High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid
- (2010) Werner J. Heinz et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Macromolecules, Dendrimers, and Nanomaterials in Magnetic Resonance Imaging: The Interplay between Size, Function, and Pharmacokinetics
- (2010) Aaron Joseph L. Villaraza et al. CHEMICAL REVIEWS
- Vascular Mechanobiology
- (2009) Joji Ando et al. CIRCULATION JOURNAL
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications
- (2009) Ruirui Qiao et al. JOURNAL OF MATERIALS CHEMISTRY
- Magnetic resonance relaxation properties of superparamagnetic particles
- (2009) Yves Gossuin et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
- (2008) Sophie Laurent et al. CHEMICAL REVIEWS
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search